 Christina Roark
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell, gamma-delta | 26 | 2013 | 101 | 2.260 |
Why?
| | T-Lymphocyte Subsets | 19 | 2013 | 425 | 1.710 |
Why?
| | HLA-DRB1 Chains | 3 | 2025 | 112 | 1.490 |
Why?
| | Interleukin-17 | 9 | 2013 | 119 | 1.070 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1167 | 0.850 |
Why?
| | Glutamic Acid | 1 | 2025 | 246 | 0.790 |
Why?
| | Collagen | 2 | 2025 | 446 | 0.790 |
Why?
| | Immune Tolerance | 1 | 2025 | 362 | 0.780 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 87 | 0.730 |
Why?
| | Transplantation, Haploidentical | 3 | 2024 | 22 | 0.630 |
Why?
| | Epitopes | 3 | 2016 | 480 | 0.580 |
Why?
| | Genetic Predisposition to Disease | 4 | 2016 | 2412 | 0.580 |
Why?
| | HLA Antigens | 3 | 2024 | 237 | 0.570 |
Why?
| | T-Lymphocytes | 8 | 2025 | 1993 | 0.560 |
Why?
| | Alleles | 5 | 2025 | 890 | 0.440 |
Why?
| | Freund's Adjuvant | 1 | 2013 | 18 | 0.410 |
Why?
| | HLA-B Antigens | 2 | 2024 | 62 | 0.410 |
Why?
| | Collagen Type II | 2 | 2016 | 53 | 0.400 |
Why?
| | Peptides | 3 | 2016 | 980 | 0.360 |
Why?
| | Mice | 31 | 2025 | 17757 | 0.290 |
Why?
| | Pulmonary Fibrosis | 5 | 2010 | 399 | 0.290 |
Why?
| | Mice, Transgenic | 7 | 2025 | 2163 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 6 | 2013 | 337 | 0.250 |
Why?
| | Arthritis, Experimental | 1 | 2007 | 147 | 0.250 |
Why?
| | Skin Transplantation | 1 | 2025 | 85 | 0.220 |
Why?
| | Alveolitis, Extrinsic Allergic | 3 | 2009 | 97 | 0.220 |
Why?
| | Animals | 33 | 2025 | 36847 | 0.210 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 306 | 0.210 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2022 | 368 | 0.210 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 287 | 0.210 |
Why?
| | HLA-A Antigens | 1 | 2022 | 55 | 0.190 |
Why?
| | HLA-C Antigens | 1 | 2022 | 35 | 0.190 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2022 | 202 | 0.190 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 105 | 0.190 |
Why?
| | Autoimmune Diseases | 3 | 2019 | 460 | 0.180 |
Why?
| | Ovalbumin | 5 | 2009 | 183 | 0.180 |
Why?
| | Lymph Nodes | 3 | 2013 | 492 | 0.180 |
Why?
| | Bronchial Hyperreactivity | 3 | 2008 | 111 | 0.180 |
Why?
| | Recurrence | 1 | 2024 | 1055 | 0.170 |
Why?
| | Mice, Inbred C57BL | 15 | 2013 | 5749 | 0.170 |
Why?
| | Mice, Inbred DBA | 2 | 2013 | 200 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2024 | 488 | 0.170 |
Why?
| | Major Histocompatibility Complex | 1 | 2001 | 227 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2010 | 1095 | 0.160 |
Why?
| | Flow Cytometry | 6 | 2016 | 1180 | 0.160 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2019 | 17 | 0.150 |
Why?
| | Listeriosis | 4 | 2008 | 70 | 0.150 |
Why?
| | Mice, Knockout | 9 | 2013 | 3008 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 2 | 2009 | 69 | 0.140 |
Why?
| | Gene Frequency | 2 | 2019 | 520 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3710 | 0.130 |
Why?
| | Hybridomas | 5 | 2005 | 237 | 0.130 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 26 | 0.130 |
Why?
| | Vimentin | 1 | 2016 | 52 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1058 | 0.120 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 385 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 374 | 0.120 |
Why?
| | Th17 Cells | 2 | 2013 | 108 | 0.110 |
Why?
| | Lupus Nephritis | 2 | 2008 | 63 | 0.110 |
Why?
| | Peptides, Cyclic | 1 | 2016 | 259 | 0.110 |
Why?
| | Interferon-gamma | 3 | 2013 | 789 | 0.110 |
Why?
| | Genotype | 2 | 2022 | 1914 | 0.110 |
Why?
| | Inflammation | 2 | 2009 | 2835 | 0.100 |
Why?
| | HEK293 Cells | 1 | 2016 | 729 | 0.100 |
Why?
| | Homeostasis | 2 | 2009 | 619 | 0.100 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 443 | 0.100 |
Why?
| | Glycoproteins | 2 | 2008 | 342 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 99 | 0.100 |
Why?
| | Haplotypes | 1 | 2014 | 494 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2138 | 0.090 |
Why?
| | Cell Line | 2 | 2016 | 2838 | 0.090 |
Why?
| | Immunity, Innate | 2 | 2008 | 825 | 0.090 |
Why?
| | CD8 Antigens | 2 | 2008 | 75 | 0.090 |
Why?
| | Mice, Inbred NZB | 4 | 2008 | 16 | 0.090 |
Why?
| | Ligands | 4 | 2022 | 661 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2216 | 0.080 |
Why?
| | Adoptive Transfer | 5 | 2009 | 224 | 0.080 |
Why?
| | Alum Compounds | 1 | 2009 | 22 | 0.080 |
Why?
| | Saccharopolyspora | 1 | 2009 | 6 | 0.080 |
Why?
| | beta 2-Microglobulin | 1 | 2009 | 50 | 0.080 |
Why?
| | Keratitis | 1 | 2009 | 15 | 0.080 |
Why?
| | Humans | 13 | 2024 | 136765 | 0.080 |
Why?
| | Interleukins | 1 | 2010 | 250 | 0.070 |
Why?
| | Antibodies, Monoclonal | 4 | 2004 | 1430 | 0.070 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2009 | 70 | 0.070 |
Why?
| | Natural Killer T-Cells | 1 | 2009 | 67 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2024 | 15504 | 0.070 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 137 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 94 | 0.070 |
Why?
| | Endogenous Retroviruses | 1 | 2008 | 37 | 0.070 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1150 | 0.070 |
Why?
| | Spleen | 3 | 2009 | 514 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2009 | 342 | 0.070 |
Why?
| | Listeria monocytogenes | 2 | 2008 | 126 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2009 | 250 | 0.070 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 187 | 0.060 |
Why?
| | Allergens | 2 | 2009 | 408 | 0.060 |
Why?
| | Autoantigens | 3 | 2008 | 428 | 0.060 |
Why?
| | Autoantibodies | 3 | 2019 | 1496 | 0.060 |
Why?
| | Liver Diseases | 1 | 2008 | 311 | 0.060 |
Why?
| | Antibody Affinity | 1 | 2005 | 60 | 0.060 |
Why?
| | Genes, MHC Class II | 1 | 2005 | 74 | 0.060 |
Why?
| | Lung | 3 | 2010 | 4062 | 0.060 |
Why?
| | Lupus Vulgaris | 1 | 2004 | 5 | 0.060 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 18 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 981 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2008 | 484 | 0.060 |
Why?
| | Male | 8 | 2024 | 67311 | 0.060 |
Why?
| | Retroviridae Infections | 1 | 2004 | 47 | 0.060 |
Why?
| | Bacillus subtilis | 3 | 2010 | 66 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 311 | 0.050 |
Why?
| | Disease Models, Animal | 6 | 2009 | 4282 | 0.050 |
Why?
| | Methacholine Chloride | 1 | 2003 | 52 | 0.050 |
Why?
| | HLA-DP beta-Chains | 1 | 2024 | 86 | 0.050 |
Why?
| | Adult | 4 | 2024 | 37631 | 0.050 |
Why?
| | Female | 10 | 2024 | 72795 | 0.050 |
Why?
| | Epidermis | 1 | 2003 | 157 | 0.050 |
Why?
| | Myelodysplastic Syndromes | 1 | 2024 | 134 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7585 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2005 | 387 | 0.050 |
Why?
| | Reference Values | 1 | 2003 | 816 | 0.050 |
Why?
| | Graft vs Host Disease | 1 | 2024 | 248 | 0.050 |
Why?
| | Cyclophosphamide | 1 | 2022 | 247 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2022 | 98 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1269 | 0.050 |
Why?
| | Hybrid Cells | 1 | 2001 | 49 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2005 | 718 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2008 | 1982 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2001 | 156 | 0.040 |
Why?
| | Biological Evolution | 1 | 2024 | 467 | 0.040 |
Why?
| | Antigen-Antibody Complex | 1 | 2000 | 90 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2005 | 913 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 2019 | 126 | 0.040 |
Why?
| | Child, Preschool | 1 | 2014 | 10997 | 0.040 |
Why?
| | Cytokines | 4 | 2009 | 2084 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 152 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 614 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2009 | 298 | 0.040 |
Why?
| | Young Adult | 2 | 2024 | 13127 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 2 | 2009 | 388 | 0.030 |
Why?
| | Middle Aged | 3 | 2024 | 33228 | 0.030 |
Why?
| | Lymphocyte Depletion | 2 | 2009 | 135 | 0.030 |
Why?
| | Solubility | 2 | 2008 | 245 | 0.030 |
Why?
| | Mice, Congenic | 2 | 2008 | 23 | 0.030 |
Why?
| | Autoimmunity | 1 | 2001 | 908 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 851 | 0.030 |
Why?
| | Aged | 2 | 2024 | 23794 | 0.030 |
Why?
| | Adolescent | 1 | 2014 | 21382 | 0.030 |
Why?
| | Child | 1 | 2014 | 21819 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2016 | 4191 | 0.030 |
Why?
| | Immunization | 2 | 2004 | 411 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2184 | 0.020 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2010 | 56 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10745 | 0.020 |
Why?
| | Receptors, Interleukin-17 | 1 | 2009 | 5 | 0.020 |
Why?
| | Farmer's Lung | 1 | 2009 | 3 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2009 | 50 | 0.020 |
Why?
| | Receptors, Interleukin | 1 | 2009 | 45 | 0.020 |
Why?
| | Orchiectomy | 1 | 2009 | 71 | 0.020 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2008 | 38 | 0.020 |
Why?
| | Listeria | 1 | 2008 | 5 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2009 | 216 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 168 | 0.020 |
Why?
| | Interleukin-13 | 1 | 2009 | 149 | 0.020 |
Why?
| | Cornea | 1 | 2009 | 137 | 0.020 |
Why?
| | Th2 Cells | 1 | 2009 | 176 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 233 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 319 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2009 | 683 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 518 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2007 | 51 | 0.020 |
Why?
| | Cell Separation | 1 | 2008 | 317 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2008 | 201 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 656 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2008 | 195 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2006 | 142 | 0.020 |
Why?
| | Cell Movement | 1 | 2010 | 968 | 0.020 |
Why?
| | Cell Count | 1 | 2006 | 323 | 0.020 |
Why?
| | Hypersensitivity | 1 | 2009 | 257 | 0.020 |
Why?
| | Antigens | 1 | 2007 | 358 | 0.020 |
Why?
| | Lymphopenia | 1 | 2005 | 62 | 0.010 |
Why?
| | Interleukin-7 | 1 | 2005 | 61 | 0.010 |
Why?
| | Ambrosia | 1 | 2005 | 7 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2008 | 513 | 0.010 |
Why?
| | Interleukin-15 | 1 | 2005 | 97 | 0.010 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2004 | 11 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 2005 | 63 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 269 | 0.010 |
Why?
| | Antigens, Plant | 1 | 2005 | 54 | 0.010 |
Why?
| | Cross Reactions | 1 | 2004 | 133 | 0.010 |
Why?
| | Retroviridae | 1 | 2004 | 97 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 324 | 0.010 |
Why?
| | Binding Sites, Antibody | 1 | 2004 | 42 | 0.010 |
Why?
| | Myeloid Cells | 1 | 2005 | 148 | 0.010 |
Why?
| | Plant Proteins | 1 | 2005 | 113 | 0.010 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 84 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2004 | 202 | 0.010 |
Why?
| | Endopeptidases | 1 | 2004 | 90 | 0.010 |
Why?
| | Goblet Cells | 1 | 2003 | 22 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2004 | 148 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2003 | 115 | 0.010 |
Why?
| | Pulmonary Eosinophilia | 1 | 2003 | 27 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 2003 | 150 | 0.010 |
Why?
| | Antibody Formation | 1 | 2004 | 298 | 0.010 |
Why?
| | Hyperplasia | 1 | 2003 | 175 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2060 | 0.010 |
Why?
| | Bacteria | 1 | 2009 | 854 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2792 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2710 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2750 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2003 | 405 | 0.010 |
Why?
| | Chromatin | 1 | 2004 | 519 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 844 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 137 | 0.010 |
Why?
| | Cell Membrane | 1 | 2004 | 735 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 887 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 297 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2605 | 0.010 |
Why?
| | Genetic Markers | 1 | 2000 | 344 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 3946 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1935 | 0.010 |
Why?
| | Aging | 1 | 2009 | 1864 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2475 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2004 | 1094 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 6808 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2000 | 659 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2004 | 3405 | 0.010 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1993 | 8 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1993 | 2831 | 0.000 |
Why?
|
|
Roark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|